TTTY3B
associated omics dataQ-omics provides the consensus-scored TTTY3B profile across patient tissues and cancer cell-line models. TTTY3B expression is associated with patient survival in 1 of 34 cancer types, with the highest sampling consensus in THCA.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for TTTY3B — synthetic lethality, tumor antigen, and pembrolizumab response.
View premium →Survival associations
This table summarizes TTTY3B survival associations across molecular data types. TTTY3B RNA expression shows survival associations in the most cancer types (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible TTTY3B RNA expression–survival associations across cancer types. High TTTY3B expression shows unfavorable associations in THCA. The THCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify THCA as the clearest survival context for TTTY3B RNA expression.
